Bold and Bountiful
Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics
Kripa Mahalingam - July 11, 2017
Early Mover
What makes Intas the most valuable privately-held pharma company in India
Krishna Gopalan - June 09, 2017
Much-needed restorative
Billionaire investor John Paulson comes to the rescue of the drugmaker Mylan with a 7-million-share purchase
Team Outlook Business - June 16, 2015
A new prescription
Tectonic changes in the US generic drugs market is causing huge shifts in Indian pharma’s strategies as well
Team Outlook Business - December 17, 2015